Prosecution Insights
Last updated: April 17, 2026
Application No. 18/596,149

METHOD FOR PROMOTING TILLERING OF GRAMINEOUS PLANTS

Non-Final OA §102
Filed
Mar 05, 2024
Examiner
HAGOPIAN, CASEY SHEA
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
unknown
OA Round
1 (Non-Final)
54%
Grant Probability
Moderate
1-2
OA Rounds
3y 5m
To Grant
88%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allow Rate
304 granted / 558 resolved
-5.5% vs TC avg
Strong +33% interview lift
Without
With
+33.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
50 currently pending
Career history
608
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
40.9%
+0.9% vs TC avg
§102
14.8%
-25.2% vs TC avg
§112
25.5%
-14.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 558 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims Claim 1 is pending. Information Disclosure Statement The IDS dated 3/5/2024 has been considered. A signed copy is enclosed herewith. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Naik et al. (“Effect of a root growth promoter on selected crops grown in India”, Plat Physiol. Rep., 6 April 2020, vol. 25, no. 2, pp. 284-297; hereafter as “Naik”). The instant claim is drawn to a method for promoting tillering of gramineous plants comprising treating gramineous plants with a compound represented by Formula (I): PNG media_image1.png 138 290 media_image1.png Greyscale wherein R represents a hydrogen atom or a hydroxy group; and X represents a halogen atom; or a salt thereof. Regarding instant claim 1, Naik teaches treating gramineous plants (e.g., rice) with a compound known as SomRE having the following structure: PNG media_image2.png 99 150 media_image2.png Greyscale (i.e., structure of Formula (I), wherein R represents a hydrogen atom and X represents the halogen atom, bromide) (Abstract; Fig. 2a). It is noted that the instant specification discloses that the compound is used in the form of a 1.0 ppm to 1.0 ppm aqueous solution ([0019] of the instant specification). Naik also teaches using aqueous solutions of SomRE in concentrations of 0.1 and 1.0 ppm (page 285, right col., 1st full para.; page 287, left col.). Naik teaches treatment with SomRE resulted in improved root length and shoot height and, in turn, improved yield (Abstract; pg. 290). While Naik does not explicitly recite, “for promoting tillering”, MPEP 2112.02 states, The discovery of a new use for an old structure based on unknown properties of the structure might be patentable to the discoverer as a process of using. In re Hack, 245 F.2d 246, 248, 114 USPQ 161, 163 (CCPA 1957). However, when the claim recites using an old composition or structure and the "use" is directed to a result or property of that composition or structure, then the claim is anticipated. In re May, 574 F.2d 1082, 1090, 197 USPQ 601, 607 (CCPA 1978) (Claims 1 and 6, directed to a method of effecting nonaddictive analgesia (pain reduction) in animals, were found to be anticipated by the applied prior art which disclosed the same compounds, as well as a method of using them for effecting analgesia but which was silent as to addiction. The court upheld the rejection and stated that the inventors had merely found a new property of the compound and such a discovery did not constitute a new use. The court went on to reverse the obviousness rejection of claims 2-5 and 7-10 which recited a process of using a new compound. The court relied on evidence showing that the nonaddictive property of the new compound was unexpected.). See also In re Tomlinson, 363 F.2d 928, 150 USPQ 623 (CCPA 1966) (The claim was directed to a process of inhibiting light degradation of polypropylene by mixing it with one of a genus of compounds, including nickel dithiocarbamate. A reference taught mixing polypropylene with nickel dithiocarbamate to lower heat degradation. The court held that the claims read on the obvious process of mixing polypropylene with the nickel dithiocarbamate and that the preamble of the claim was merely directed to the result of mixing the two materials. "While the references do not show a specific recognition of that result, its discovery by appellants is tantamount only to finding a property in the old composition." 363 F.2d at 934, 150 USPQ at 628 (emphasis in original)). Emphasis added. In this instance, Naik teaches the method step of treating gramineous plants with a composition represented by Formula (I) in the same amounts as disclosed in the instant specification. One would reasonably expect performing the method taught by Naik would necessarily result in claimed property/effect of promoting tillering of gramineous plants. Thus, the teachings of Naik render the claim anticipated. Conclusion All claims have been rejected; no claims are allowed. Correspondence Any inquiry concerning this communication or earlier communications from the examiner should be directed to CASEY HAGOPIAN whose telephone number is (571)272-6097. The examiner can normally be reached on M-F 9:00 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sue Liu can be reached on 571-272-5539. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CASEY S HAGOPIAN/Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Mar 05, 2024
Application Filed
Mar 07, 2026
Non-Final Rejection — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12569597
METHODS FOR FORMING STENTS MODIFIED WITH MATERIAL COMPRISING AMNION TISSUE
2y 5m to grant Granted Mar 10, 2026
Patent 12551414
Systems And Methods For Delivering Active Agents
2y 5m to grant Granted Feb 17, 2026
Patent 12539213
GROWTH FACTOR TRANSDUCED CELL-LOADED CERAMIC SCAFFOLD FOR BONE REGENERATION AND REPAIR
2y 5m to grant Granted Feb 03, 2026
Patent 12527329
COMPOSITIONS AND METHODS RELATING TO INSECTICIDES
2y 5m to grant Granted Jan 20, 2026
Patent 12521258
ANTICOAGULANT COMPOUNDS AND METHODS AND DEVICES FOR THEIR USE
2y 5m to grant Granted Jan 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
54%
Grant Probability
88%
With Interview (+33.0%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 558 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month